Not every face can tolerate the power of retinol, but most can appreciate its more sensitive, skin-friendly alternatives, like bakuchiol. All this to say, it’s a powerhouse ingredient that doesn’t get enough credit. But in the Luna Nectar Futurize Botanical Retinol Alternative Boosting Serum , it’s the star of the show. So much so, even its name alludes to the standout ingredient. The elixir is also made with hydrating squalane and rosehip seed oils to add extra nourishment to skin while the fine line-fighting is going on. The Luna Nectar Futurize Botanical Retinol Alternative Boosting Serum was in the June Allure Beauty Box .
- Ingredient signalCoverage centres on retinol, pay attention to concentration, vehicle, and pairings in your routine before changing anything material.
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
L-Carnitine, an amino acid derivative critical for fatty acid metabolism, exhibits anti-inflammatory, antioxidant, and cytoprotective properties, with emerging applications in dermatology. This review explores its therapeutic potential, both topically and systemically, and its role as a biomarker in various skin disorders. A systematic search of Medline, EMBASE, and PubMed (1946-January 2025) was conducted, focusing on L-carnitine and dermatologic conditions, excluding acetyltransferases, acyltransferases, breast, and genetic metabolic diseases.
Applications of bakuchiol in dermatology: Systematic review of the literature.
Bakuchiol (BAK), a meroterpene phenol abundant in the plant Psoralea corylifolia, is an emerging cosmeceutical agent with promising anti-aging, anti-inflammatory, and antibacterial properties. The trend for "clean" skincare products and search for anti-aging retinoid alternatives have poised BAK as a "must-have" ingredient in skincare. Our aim was to review the data for the applications of BAK in dermatology.
Drug-Induced Melasma in Patients on 5-Alpha Reductase Inhibitors: A Case Report.
Melasma is a chronic hyperpigmentation disorder with pathogenesis linked to hormonal mediation, ultraviolet and heat exposure, and genetic predisposition. Five-alpha reductase inhibitors (5-ARIs), including finasteride and dutasteride, are widely prescribed for treatment of benign prostatic hyperplasia (BPH) and off-label for androgen-mediated dermatologic conditions, yet pigmentary adverse effects are rarely reported. To date, only one case documenting melasma following 5-ARI use has been published.
This intelligence brief synthesizes reporting from beauty and dermatology industry publications.
View source →